Does CAPIVASERTIB Cause Disease progression? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Disease progression have been filed in association with CAPIVASERTIB (TRUQAP). This represents 3.6% of all adverse event reports for CAPIVASERTIB.
61
Reports of Disease progression with CAPIVASERTIB
3.6%
of all CAPIVASERTIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Disease progression From CAPIVASERTIB?
Of the 61 reports, 1 (1.6%) resulted in death, 2 (3.3%) required hospitalization.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for CAPIVASERTIB.
What Other Side Effects Does CAPIVASERTIB Cause?
Diarrhoea (278)
Rash (253)
Death (228)
Hyperglycaemia (152)
Nausea (96)
Vomiting (81)
Blood glucose increased (70)
Fatigue (67)
Malignant neoplasm progression (62)
Pyrexia (55)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which CAPIVASERTIB Alternatives Have Lower Disease progression Risk?
CAPIVASERTIB vs CAPLACIZUMAB
CAPIVASERTIB vs CAPLACIZUMAB-YHDP
CAPIVASERTIB vs CAPMATINIB
CAPIVASERTIB vs CAPREOMYCIN
CAPIVASERTIB vs CAPSAICIN